首页> 外文期刊>BMC Surgery >Prospective multicentre cohort study of patient-reported outcomes and complications following major abdominal neoplastic surgery (PATRONUS) – study protocol for a CHIR- Net student-initiated German medical audit study (CHIR- Net SIGMA study)
【24h】

Prospective multicentre cohort study of patient-reported outcomes and complications following major abdominal neoplastic surgery (PATRONUS) – study protocol for a CHIR- Net student-initiated German medical audit study (CHIR- Net SIGMA study)

机译:重大腹部肿瘤手术(PATRONUS)后患者报告的结局和并发症的多中心前瞻性研究– CHIR-Net学生发起的德国医学审计研究的研究方案(CHIR-Net SIGMA研究)

获取原文
       

摘要

One of the most important aspects of designing a clinical trial is selecting appropriate outcomes. Patient-reported outcomes (PROs) can provide a personal assessment of the burden and impact of a malignant disease and its treatment. PROs comprise a wide range of outcomes including basic clinical symptom scores and complex metrics such as health-related quality of life (HRQoL). There is limited data on how postoperative complications following cancer surgery affect symptoms and HRQoL. For this reason the primary aim of the PATRONUS study is to investigate how perioperative complications affect cancer-related symptoms and HRQoL in patients undergoing abdominal cancer surgery. The PATRONUS study is designed and will be initiated and conducted by medical students under the direct supervision of clinician scientists based on the concept of inquiry-based learning. PATRONUS is a non-interventional prospective multicentre cohort study. Patients undergoing elective oncological abdominal surgery will be recruited at regional centres of the clinical network of the German Surgical Society (CHIR-Net) and associated hospitals. A core set of 12 cancer associated symptoms will be assessed via the PRO version of the Common Terminology Criteria for Adverse Events. The cancer-specific HRQoL will be measured via the computerised adaptive testing version of the European Organisation for Research and Treatment of Cancer (EORTC) QLQ-C30. PROs will be measured eight times over a period of six months. The short-term clinical outcome measure is the rate of postoperative complications (grade II to V) within 30?days according to the Clavien-Dindo classification. The long-term clinical outcome is overall survival within six months postoperative. PATRONUS will provide essential insights into the patients’ assessment of their well-being and quality of life in direct relation to clinical outcome parameters following abdominal cancer surgery. Furthermore, PATRONUS will investigate the feasibility of multicentre student-led clinical research. German Clinical Trials Register: DRKS00013035 (registered on October 26, 2017). Universal Trial Number (UTN): U1111–1202-8863.
机译:设计临床试验最重要的方面之一是选择适当的结果。患者报告的结局(PRO)可以对恶性疾病及其治疗的负担和影响进行个人评估。 PRO的结果范围很广,包括基本的临床症状评分和复杂的指标,例如与健康相关的生活质量(HRQoL)。关于癌症手术后术后并发症如何影响症状和HRQoL的数据有限。因此,PATRONUS研究的主要目的是研究围手术期并发症如何影响接受腹部癌手术的患者的癌症相关症状和HRQoL。 PATRONUS研究的设计将由医学生根据基于询问的学习概念在临床医生的直接监督下发起和进行。 PATRONUS是一项非干预性前瞻性多中心队列研究。进行选择性腹部肿瘤外科手术的患者将在德国外科医师学会(CHIR-Net)和相关医院的临床网络区域中心招募。将通过PRO版本的不良事件通用术语标准评估12种与癌症相关的症状的核心组。特定于癌症的HRQoL将通过欧洲癌症研究与治疗组织(EORTC)QLQ-C30的计算机自适应测试版本进行测量。在六个月的时间内将对PRO进行八次测量。短期临床结果指标是根据Clavien-Dindo分类在30天之内的术后并发症发生率(II级至V级)。长期临床结果是术后六个月内的总体存活率。 PATRONUS将为患者对他们的幸福感和生活质量评估提供重要见解,这些评估与腹癌手术后的临床结果参数直接相关。此外,PATRONUS将研究由多中心学生主导的临床研究的可行性。德国临床试验注册证:DRKS00013035(2017年10月26日注册)。通用试验编号(UTN):U1111–1202-8863。

著录项

相似文献

  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号